Physicians Total Care Recalls Subpotent Enjuvia Tablets
Physicians Total Care is recalling specific lots of Enjuvia tablets because they failed potency tests. The affected medication may contain less active ingredient than labeled.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as unlikely to cause adverse health consequences. The hazard is a subpotent drug, which is a quality issue rather than a direct safety threat like contamination or mislabeling of a dangerous substance.
Plain-English summary
Physicians Total Care, Inc. is recalling specific lots of Enjuvia (synthetic conjugated estrogens, B) tablets, 0.625 mg. The recall involves 9 bottles of the 30-count prescription medication. The product was manufactured by Teva Pharmaceuticals USA and repacked and distributed by Physicians Total Care, Inc.
The recall was initiated because the medication produced low Out of Specification (OOS) assay results, indicating that the tablets are subpotent. This means the medication may not contain the full amount of the active ingredient stated on the label. The affected lots are identified by Lot # 62QI (Expiration 01/12) and Lot # 6DYQ (Expiration 08/12).
The distribution pattern is listed as VA. Patients who have been prescribed this specific medication should consult their healthcare provider for guidance on alternative treatments or further instructions.
The recalled product
- Product
- Enjuvia (synthetic conjugated estrogens, B) tablets, 0.625 mg, 30-count tablets per bottle, Rx only, Mfg. By: Teva Pharmaceuticals USA, Sellersville PA 18960; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK 74146; NDC 54868-6163-1.
- Manufacturer
- Physicians Total Care, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 9
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 62QI
- Exp 01/12
- 6DYQ
- Exp 08/12
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 3 recalled by Physicians Total Care, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Physicians Total Care, Inc.
See all →- ModeratePhysicians Total Care Recalls Cephalexin Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2014-11-12
- LowPhysicians Total Care Recalls Loratadine Tablets Due to Chipped or Broken Pieces
FDA (Drugs) · 2014-11-12
- SeverePhysicians Total Care Recalls Carisoprodol Tablets Due to Foreign Substance
FDA (Drugs) · 2014-01-01
- ModeratePhysicians Total Care Recalls Belladonna Alkaloids Tablets Due to Foreign Substance
FDA (Drugs) · 2013-08-07
- ModeratePhysicians Total Care Recalls Metronidazole Tablets for Weight Specification Failures
FDA (Drugs) · 2013-06-12
Same hazard · subpotent drug
See all →- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02